Valeant Pharma (VRX) options active Dow Jones says talks with Takeda beak down

November 30, 2016 10:07 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Valeant Pharma (NYSE: VRX) December weekly 17 calls and December 16 puts are active on total call volume of 13K contracts (9K puts) after Dow Jones reports talks with Takeda over Salix break down. December weekly call option implied volatility is at 104, December is at 78, January is at 85; compared to its 52-week range of 53 to 172.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment